Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Deepesh Lad, Qing Huang, Romy Hoeppli, Rosa Garcia, Lixin Xu, Megan Levings, Kevin Song & Raewyn Broady. (2019) Evaluating the role of Tregs in the progression of multiple myeloma. Leukemia & Lymphoma 60:9, pages 2134-2142.
Read now
Read now
Giulia Di Lullo, Magda Marcatti & Maria Pia Protti. (2016) Non-redundant roles for Th17 and Th22 cells in multiple myeloma clinical correlates. OncoImmunology 5:4.
Read now
Read now
Kirsty Rady, Euan Wallace & John F. Seymour. (2015) An uncomplicated pregnancy in a woman with smoldering Waldenström macroglobulinemia. Leukemia & Lymphoma 56:7, pages 2222-2224.
Read now
Read now
Articles from other publishers (54)
Mahya Aghaee, Urszula Ledzewicz, Michael Robbins, Natalie Bezman, Hearn Jay Cho & Helen Moore. (2023) Determining optimal combination regimens for patients with multiple myeloma. European Journal of Pharmaceutical Sciences 187, pages 106492.
Crossref
Crossref
Mengping Chen, Jinxing Jiang & Jian Hou. (2023) Single-cell technologies in multiple myeloma: new insights into disease pathogenesis and translational implications. Biomarker Research 11:1.
Crossref
Crossref
Anna Kulikowska de Nałęcz, Lidia Ciszak, Lidia Usnarska-Zubkiewicz, Edyta Pawlak, Irena Frydecka, Magdalena Szmyrka & Agata Kosmaczewska. (2023) Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors. International Journal of Molecular Sciences 24:6, pages 5730.
Crossref
Crossref
Federica Plano, Anna Maria Corsale, Emilia Gigliotta, Giulia Camarda, Candida Vullo, Marta Di Simone, Mojtaba Shekarkar Azgomi, Maria Speciale, Melania Carlisi, Nadia Caccamo, Francesco Dieli, Serena Meraviglia, Sergio Siragusa & Cirino Botta. (2023) Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again. Hematology Reports 15:1, pages 23-49.
Crossref
Crossref
Elham Roshandel, Haniyeh Ghaffari-Nazari, Mozhdeh Mohammadian, Maryam Salimi, Saeid Abroun, Reza Mirfakhraie & Abbas Hajifathali. (2023) NK cell therapy in relapsed refractory multiple myeloma. Clinical Immunology 246, pages 109168.
Crossref
Crossref
Giuseppe Bertuglia, Lorenzo Cani, Alessandra Larocca, Francesca Gay & Mattia D’Agostino. (2022) Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?. International Journal of Molecular Sciences 23:24, pages 15879.
Crossref
Crossref
Cinnie Yentia Soekojo & Wee Joo Chng. (2022) The evolution of immune dysfunction in multiple myeloma. European Journal of Haematology 109:5, pages 415-424.
Crossref
Crossref
Zhigang Yi, Tao Ma, Jia Liu, Wenting Tie, Yanhong Li, Jun Bai, Lijuan Li & Liansheng Zhang. (2022) The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma. Frontiers in Immunology 13.
Crossref
Crossref
Katalin Balázs, Zsuzsa S. Kocsis, Péter Ágoston, Kliton Jorgo, László Gesztesi, Gyöngyi Farkas, Gábor Székely, Zoltán Takácsi-Nagy, Csaba Polgár, Géza Sáfrány, Zsolt Jurányi & Katalin Lumniczky. (2022) Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations. Cancers 14:13, pages 3058.
Crossref
Crossref
Ivana Lagreca, Giovanni Riva, Vincenzo Nasillo, Patrizia Barozzi, Ilaria Castelli, Sabrina Basso, Francesca Bettelli, Davide Giusti, Angela Cuoghi, Paola Bresciani, Andrea Messerotti, Andrea Gilioli, Valeria Pioli, Corrado Colasante, Daniela Vallerini, Ambra Paolini, Monica Maccaferri, Francesca Donatelli, Fabio Forghieri, Monica Morselli, Elisabetta Colaci, Giovanna Leonardi, Roberto Marasca, Leonardo Potenza, Rossella Manfredini, Enrico Tagliafico, Tommaso Trenti, Patrizia Comoli & Mario Luppi. (2022) The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches. International Journal of Molecular Sciences 23:9, pages 5242.
Crossref
Crossref
Vanessa Desantis, Francesco Domenico Savino, Antonietta Scaringella, Maria Assunta Potenza, Carmela Nacci, Maria Antonia Frassanito, Angelo Vacca & Monica Montagnani. (2022) The Leading Role of the Immune Microenvironment in Multiple Myeloma: A New Target with a Great Prognostic and Clinical Value. Journal of Clinical Medicine 11:9, pages 2513.
Crossref
Crossref
Robert L. Satcher & Xiang H.-F. Zhang. (2021) Evolving cancer–niche interactions and therapeutic targets during bone metastasis. Nature Reviews Cancer 22:2, pages 85-101.
Crossref
Crossref
Franziska Füchsl & Angela M. Krackhardt. (2022) Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance. Cells 11:3, pages 410.
Crossref
Crossref
Julia Halper, Maria-Bernadette Madel & Claudine Blin-Wakkach. 2022. Bone Cancer. Bone Cancer
179
188
.
Christina Hadjiaggelidou & Eirini Katodritou. (2021) Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment. Journal of Clinical Medicine 10:19, pages 4588.
Crossref
Crossref
Anna Kulikowska de Nałęcz, Lidia Ciszak, Lidia Usnarska-Zubkiewicz, Irena Frydecka, Edyta Pawlak, Magdalena Szmyrka & Agata Kosmaczewska. (2021) Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients. International Journal of Molecular Sciences 22:17, pages 9298.
Crossref
Crossref
Vanessa Innao, Alessandro Allegra, Lia Ginaldi, Giovanni Pioggia, Massimo De Martinis, Caterina Musolino & Sebastiano Gangemi. (2021) Reviewing the Significance of Vitamin D Substitution in Monoclonal Gammopathies. International Journal of Molecular Sciences 22:9, pages 4922.
Crossref
Crossref
Criselle D'Souza, H. Miles Prince & Paul J. Neeson. (2021) Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs. Frontiers in Immunology 12.
Crossref
Crossref
Douglas E. Joshua, Slavica Vuckovic, James Favaloro, Ka Hei Aleks Lau, Shihong Yang, Christian E. Bryant, John Gibson & Phoebe Joy Ho. (2021) Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma. Frontiers in Immunology 12.
Crossref
Crossref
Chiara Montironi, Cristina Muñoz-Pinedo & Eric Eldering. (2021) Hematopoietic versus Solid Cancers and T Cell Dysfunction: Looking for Similarities and Distinctions. Cancers 13:2, pages 284.
Crossref
Crossref
Michael Heider, Katharina Nickel, Marion Högner & Florian Bassermann. (2021) Multiple Myeloma: Molecular Pathogenesis and Disease Evolution. Oncology Research and Treatment 44:12, pages 672-681.
Crossref
Crossref
Yue Wang, Wanjing Feng & Peng Liu. (2020) Genotype–immunophenotype analysis reveals the immunogenomic subtype and prognosis of multiple myeloma. Carcinogenesis 41:12, pages 1746-1754.
Crossref
Crossref
Slavisa Ninkovic & Hang Quach. (2020) Shaping the Treatment Paradigm Based on the Current Understanding of the Pathobiology of Multiple Myeloma: An Overview. Cancers 12:11, pages 3488.
Crossref
Crossref
Konstantinos Papadimitriou, Nikolaos Tsakirakis, Panagiotis Malandrakis, Panagiotis Vitsos, Andreas Metousis, Nikolaos Orologas-Stavrou, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Panagiotis Pothos, Despina Fotiou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios-Athanasios Dimopoulos, Evangelos Terpos, Ourania E. Tsitsilonis & Ioannis V. Kostopoulos. (2020) Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma. Cancers 12:11, pages 3245.
Crossref
Crossref
Matthew Ho, Chia Yin Goh, Ashish Patel, Susannah Staunton, Ronan O’Connor, Marc Godeau & Giada Bianchi. (2020) Role of the Bone Marrow Milieu in Multiple Myeloma Progression and Therapeutic Resistance. Clinical Lymphoma Myeloma and Leukemia 20:10, pages e752-e768.
Crossref
Crossref
Nouf Alrasheed, Lydia Lee, Ehsan Ghorani, Jake Y. Henry, Lucia Conde, Melody Chin, Daria Galas-Filipowicz, Andrew J.S. Furness, Selina J. Chavda, Huw Richards, Dunnya De-Silva, Oliver C. Cohen, Dominic Patel, Anthony Brooks, Manuel Rodriguez-Justo, Martin Pule, Javier Herrero, Sergio A. Quezada & Kwee L. Yong. (2020) Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma. Clinical Cancer Research 26:13, pages 3443-3454.
Crossref
Crossref
Noémie Leblay, Ranjan Maity, Fajer Hasan & Paola Neri. (2020) Deregulation of Adaptive T Cell Immunity in Multiple Myeloma: Insights Into Mechanisms and Therapeutic Opportunities. Frontiers in Oncology 10.
Crossref
Crossref
Rachel E. Cooke, Rachel Koldej & David Ritchie. (2019) Immunotherapeutics in Multiple Myeloma: How Can Translational Mouse Models Help?. Journal of Oncology 2019, pages 1-18.
Crossref
Crossref
Laurens E. Franssen, Tuna Mutis, Henk M. Lokhorst & Niels W. C. J. van de Donk. (2019) Immunotherapy in myeloma: how far have we come?. Therapeutic Advances in Hematology 10, pages 204062071882266.
Crossref
Crossref
Jill Gallaher, Kamila Larripa, Marissa Renardy, Blerta Shtylla, Nessy Tania, Diana White, Karen Wood, Li Zhu, Chaitali Passey, Michael Robbins, Natalie Bezman, Suresh Shelat, Hearn Jay Cho & Helen Moore. (2018) Methods for determining key components in a mathematical model for tumor–immune dynamics in multiple myeloma. Journal of Theoretical Biology 458, pages 31-46.
Crossref
Crossref
Alessandra Bandera, Elisa Colella, Mario Clerici, Giuliano Rizzardini & Andrea Gori. (2018) The contribution of immune activation and accelerated aging in multiple myeloma occurring in HIV-infected population. AIDS 32:18, pages 2841-2846.
Crossref
Crossref
Laurens E. Franssen, Inger S. Nijhof, Chad C. Bjorklund, Hsiling Chiu, Ruud Doorn, Jeroen van Velzen, Maarten Emmelot, Berris van Kessel, Mark-David Levin, Gerard M.J. Bos, Annemiek Broijl, Saskia K. Klein, Harry R. Koene, Andries C. Bloem, Aart Beeker, Laura M. Faber, Ellen van der Spek, Reinier Raymakers, Pieter Sonneveld, Sonja Zweegman, Henk M. Lokhorst, Anjan Thakurta, Xiaozhong Qian, Tuna Mutis & Niels W.C.J. van de Donk. (2018) Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory multiple myeloma patients. Oncotarget 9:74, pages 34009-34021.
Crossref
Crossref
Yu-Tzu Tai, Shih-Feng Cho & Kenneth C. Anderson. (2018) Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1. Frontiers in Immunology 9.
Crossref
Crossref
Juana J Jiménez, Tiago M Pais, Nuno Barbosa, Maria Luisa Campos, Maria Antonia Peñalver Díaz & Carmen H de Larramendi. (2018) Severe Isotype-Matched Immunosuppression (IMI) as a Potential Risk Factor for Progression of MGUS Patients. The Journal of Applied Laboratory Medicine 2:5, pages 700-710.
Crossref
Crossref
Jill Gallaher, Kamila Larripa, Urszula Ledzewicz, Marissa Renardy, Blerta Shtylla, Nessy Tania, Diana White, Karen Wood, Li Zhu, Chaitali Passey, Michael Robbins, Natalie Bezman, Suresh Shelat, Hearn Jay Cho & Helen Moore. 2018. Understanding Complex Biological Systems with Mathematics. Understanding Complex Biological Systems with Mathematics
89
122
.
Daniel E. Meyers, Satbir Thakur, Chandini M. Thirukkumaran & Don G. Morris. (2017) Oncolytic virotherapy as an immunotherapeutic strategy for multiple myeloma. Blood Cancer Journal 7:12.
Crossref
Crossref
Leo Hansmann, Arnold Han, Livius Penter, Michaela Liedtke & Mark M. Davis. (2017) Clonal Expansion and Interrelatedness of Distinct B-Lineage Compartments in Multiple Myeloma Bone Marrow. Cancer Immunology Research 5:9, pages 744-754.
Crossref
Crossref
Anna Mansour, Abdelilah Wakkach & Claudine Blin-Wakkach. (2017) Emerging Roles of Osteoclasts in the Modulation of Bone Microenvironment and Immune Suppression in Multiple Myeloma. Frontiers in Immunology 8.
Crossref
Crossref
Nicholas Burwick. (2017) Vitamin D and plasma cell dyscrasias: reviewing the significance. Annals of Hematology 96:8, pages 1271-1277.
Crossref
Crossref
Christine M. Ho, Philip L. McCarthy, Paul K. WallaceYali Zhang, Ahmad Fora, Patrick Mellors, Joseph D. TarioBenjamin L. S. McCarthy, George L. Chen, Sarah A. HolsteinSophia R. Balderman, Xuefang Cao, Bruno Paiva & Theresa Hahn. (2017) Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT. Blood Advances 1:15, pages 1056-1066.
Crossref
Crossref
D. E. Joshua, R. Brown, P. J. Ho, J. Gibson & H. Suen. 2017. Waldenström’s Macroglobulinemia. Waldenström’s Macroglobulinemia
83
94
.
Clement Chung. (2017) Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37:1, pages 129-143.
Crossref
Crossref
Paola Neri, Nizar J. Bahlis & Sagar Lonial. (2016) New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma. Clinical Cancer Research 22:24, pages 5959-5965.
Crossref
Crossref
Douglas Joshua, Hayley Suen, Ross Brown, Christian Bryant, P. Joy Ho, Derek Hart & John Gibson. (2016) The T Cell in Myeloma. Clinical Lymphoma Myeloma and Leukemia 16:10, pages 537-542.
Crossref
Crossref
H Suen, R Brown, S Yang, C Weatherburn, P J Ho, N Woodland, N Nassif, P Barbaro, C Bryant, D Hart, J Gibson & D Joshua. (2016) Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade. Leukemia 30:8, pages 1716-1724.
Crossref
Crossref
Ayse Pinar Ercetin, Mehmet Ali Ozcan, Safiye Aktas, Faize Yuksel, Serife Medeni Solmaz, Gokmen Omur Sevindik, Abdullah Katgi, Ozden Piskin & Bulent Undar. (2016) Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma. Experimental Hematology 44:4, pages 223-230.
Crossref
Crossref
Eli Muchtar, Hila Magen, Gilad Itchaki, Amos Cohen, Ra’ama Rosenfeld, Tzippy Shochat, Ran Kornowski, Zaza Iakobishvili & Pia Raanani. (2016) Uninvolved immunoglobulins predicting hematological response in newly diagnosed AL amyloidosis. Leukemia Research 41, pages 56-61.
Crossref
Crossref
Eszter Persa, Andrea Balogh, Géza Sáfrány & Katalin Lumniczky. (2015) The effect of ionizing radiation on regulatory T cells in health and disease. Cancer Letters 368:2, pages 252-261.
Crossref
Crossref
Giada Bianchi & Kenneth C. Anderson. 2015. Targeted Therapy in Translational Cancer Research. Targeted Therapy in Translational Cancer Research
145
156
.
Leo Hansmann, Lisa Blum, Chia-Hsin Ju, Michaela Liedtke, William H. Robinson & Mark M. Davis. (2015) Mass Cytometry Analysis Shows That a Novel Memory Phenotype B Cell Is Expanded in Multiple Myeloma. Cancer Immunology Research 3:6, pages 650-660.
Crossref
Crossref
Giada Bianchi & Nikhil C. Munshi. (2015) Pathogenesis beyond the cancer clone(s) in multiple myeloma. Blood 125:20, pages 3049-3058.
Crossref
Crossref
Lei Wang, Nan Jin, Anita Schmitt, Jochen Greiner, Georg Malcherek, Michael Hundemer, Jiju Mani, Dirk Hose, Marc S Raab, Anthony D. Ho, Bao-an Chen, Hartmut Goldschmidt & Michael Schmitt. (2015) T cell-based targeted immunotherapies for patients with multiple myeloma. International Journal of Cancer 136:8, pages 1751-1768.
Crossref
Crossref
T Dosani, M Carlsten, I Maric & O Landgren. (2015) The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies. Blood Cancer Journal 5:4, pages e306-e306.
Crossref
Crossref
Thibaud André, Mehdi Najar, Basile Stamatopoulos, Karlien Pieters, Olivier Pradier, Dominique Bron, Nathalie Meuleman & Laurence Lagneaux. (2014) Immune impairments in multiple myeloma bone marrow mesenchymal stromal cells. Cancer Immunology, Immunotherapy 64:2, pages 213-224.
Crossref
Crossref